Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mycobacterium tuberculosis/drug effects/isolation & purification"'
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical Mycobacterium tuberculosis (MTB) isolates from three distinct groups of patients (unselected patients, patients at high risk of drug-resistant TB and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ae2c7c6d8934ac6f021957cf9008e997
Autor:
David L. Dolinger, Pamela Nabeta, Audrey Albertini, Jimena Collantes, Elena Romancenco, Belay Tessema, Eloise Valli, Nguyen Huu Lan, Claudia M. Denkinger, Nestani Tukavdze
Publikováno v:
Journal of Clinical Microbiology
The spread of multidrug-resistant (MDR) tuberculosis (TB) and extensively drug-resistant (XDR) TB hampers global efforts in the fight against tuberculosis. To enhance the development and evaluation of diagnostic tests quickly and efficiently, well-ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582104eb91b19d82a9858884a2ce07ea
https://hdl.handle.net/20.500.12866/4660
https://hdl.handle.net/20.500.12866/4660
Publikováno v:
Revue des maladies respiratoires, Vol. 28, No 6 (2011) pp. 823-33
Over the last decade, molecular biology techniques for identifying mycobacteria in pulmonary secretions have become more and more sensitive and rapid, even in smear negative samples. Nuclear amplification techniques also allow the rapid detection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6bb96842aea4a01f03e2900345a8fac
https://doi.org/10.1016/j.rmr.2010.12.012
https://doi.org/10.1016/j.rmr.2010.12.012
Autor:
Robert H. Gilman, Patricia Sheen, Luz Caviedes, Jorge Coronel, Mirko Zimic, Alvaro Proaño, Christopher Meinzen
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 99
Summary Background Pyrazinamide (PZA) is the most important drug against the latent stage of tuberculosis (TB) and is used in both first and second line treatment regimens. The continued increase in multi-drug resistant TB and the prevalence of PZA r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18650d4ab8f9ac3d2316cd5ff0483ee4
https://pubmed.ncbi.nlm.nih.gov/27450003
https://pubmed.ncbi.nlm.nih.gov/27450003
Autor:
Magaly Espinoza, Maya Vallejo, Roxana Challapa, Rosario Castro, Faustino Torrico, Robert H. Gilman, Melissa J. Reimer-McAtee, Meredith Holtz Lora, Marco Solano, Monica J. Pajuelo, Caryn Bern, Ruth Saravia, Daniel Lozano
Publikováno v:
BMC Infectious Diseases
Background: Tuberculosis (TB) is the most common opportunistic infection and the leading cause of death in HIV-positive people worldwide. Diagnosing TB is difficult, and is more challenging in resource-scarce settings where culture-based diagnostic m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205cd8e26e47df6b1f56049a03220608
https://doi.org/10.1186/s12879-015-0966-0
https://doi.org/10.1186/s12879-015-0966-0
Autor:
Theodore G. Ganiats, Kathleen D. Eisenach, RL Jackson, Luz Caviedes, Timothy C. Rodwell, Jorge Coronel, Erik J. Groessl, AP Trollip, Kanchan Ajbani, S Klages, Elena Romancenco, Tommie C. Victor, Camilla Rodrigues, VP Vineet, Richard S. Garfein, David Moore, Edward Desmond, Antonino Catanzaro, Crudu
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 18, iss 2
Trollip, AP; Moore, D; Coronel, J; Caviedes, L; Klages, S; Victor, T; et al.(2014). Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. International Journal of Tuberculosis and Lung Disease, 18(2), 227-232. doi: 10.5588/ijtld.13.0229. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/984268pf
Trollip, AP; Moore, D; Coronel, J; Caviedes, L; Klages, S; Victor, T; et al.(2014). Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. International Journal of Tuberculosis and Lung Disease, 18(2), 227-232. doi: 10.5588/ijtld.13.0229. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/984268pf
Author(s): Trollip, AP; Moore, D; Coronel, J; Caviedes, L; Klages, S; Victor, T; Romancenco, E; Crudu, V; Ajbani, K; Vineet, VP; Rodrigues, C; Jackson, RL; Eisenach, K; Garfein, RS; Rodwell, TC; Desmond, E; Groessl, EJ; Ganiats, TG; Catanzaro, A | Ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e895b88db774752b385642c24a1e0bc
https://europepmc.org/articles/PMC4250530/
https://europepmc.org/articles/PMC4250530/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kwok-Yung Yuen, H. L. Tong, K. H. Chan, Wing-Hong Seto, KC Wong, Wing Wai Yew, CM Tam, Pak-Leung Ho, E. T. Y. Leung, C. C. Leung, Wing-Cheong Yam
Publikováno v:
Journal of clinical microbiology. 42(10)
This study evaluated the feasibility of a molecular strategy based on identification of Mycobacterium tuberculosis by IS6110 PCR or Cobas Amplicor PCR, and rpoB PCR-DNA sequencing of the 81-bp rifampin resistance determining region (RRDR) for direct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61368f2da49540eb8eb7d7bacb9d3a3e
https://pubmed.ncbi.nlm.nih.gov/15472290
https://pubmed.ncbi.nlm.nih.gov/15472290